BET BRD4 inhibitor compound II-25
CAS: 1660117-38-3
Ref. 3D-KRC11738
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
BET BRD4 inhibitor compound II-25 belongs to a class of protein inhibitors. It is orally available and can inhibit cancer cells in vitro. BET BRD4 inhibitor compound II-25 has been shown to induce cell maturation and apoptosis in myeloid leukemia cells. This drug also inhibits the methyltransferase activity of the enzyme, thereby preventing the production of inflammatory cytokines that cause inflammation. In addition, this drug has shown potential as an anticancer therapeutic by inhibiting cancer cell proliferation and inducing tumor necrosis in vivo. It is possible that BET BRD4 inhibitor compound II-25 may function as a toll-like receptor modulator because it can block TLR signaling pathways in mice.
Chemical properties
Technical inquiry about: 3D-KRC11738 BET BRD4 inhibitor compound II-25
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
